trending Market Intelligence /marketintelligence/en/news-insights/trending/lhtwkz__9eohfzotq2hkvg2 content esgSubNav
In This List

Zai Lab prices offering of American depositary shares

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Zai Lab prices offering of American depositary shares

Zai Lab Ltd. priced an underwritten public offering of 7.5 million American depositary shares at $20 each.

Each ADS represents an ordinary share of the Shanghai-based biopharmaceutical company.

Zai Lab expects to raise gross proceeds of about $150 million through the offering, which is expected to close Sept. 10, subject to customary closing conditions.

Underwriters have 30-day option to buy up to an additional 1,125,000 ADSs at the offering price.

J.P. Morgan, Citigroup, Jefferies and Leerink Partners are acting as joint book-running managers for the offering.